Sevelamer versus calcium-based phosphate binders in chronic kidney disease: what should we conclude from the evidence to date?

被引：3
作者：
Johnson, David W. [1 ]
机构：
[1] Univ Queensland, Dept Renal Med, Princess Alexandra Hosp, Brisbane, Qld, Australia
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2009年 / 24卷 / 10期
关键词：
chronic kidney disease; lanthanum; phosphate binders; sevelamer; vascular calcification; DIALYSIS PATIENTS; MORTALITY; CALCIFICATION; CARBONATE; EFFICACY; SAFETY; CHOICE;
D O I：
10.1093/ndt/gfp366
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：2970 / 2972
页数：3
相关论文
共 18 条
[1]   Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients [J].
Block, G. A. ;
Raggi, P. ;
Bellasi, A. ;
Kooienga, L. ;
Spiegel, D. M. .
KIDNEY INTERNATIONAL, 2007, 71 (05) :438-441
[2]   A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients [J].
D'Haese, PC ;
Spasovski, GB ;
Sikole, A ;
Hutchison, A ;
Freemont, TJ ;
Sulkova, S ;
Swanepoel, C ;
Pejanovic, S ;
Djukanovic, L ;
Balducci, A ;
Coen, G ;
Sulowicz, W ;
Ferreira, A ;
Torres, A ;
Curic, S ;
Popovic, M ;
Dimkovic, N ;
De Broe, ME .
KIDNEY INTERNATIONAL, 2003, 63 :S73-S78
[3]   On the evolving nature of understanding dialysis-related disorders [J].
Eknoyan, G ;
Lindberg, JS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) :S1-S3
[4]   Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis [J].
Goodman, WG ;
Goldin, J ;
Kuizon, BD ;
Yoon, C ;
Gales, B ;
Sider, D ;
Wang, Y ;
Chung, J ;
Emerick, A ;
Greaser, L ;
Elashoff, RM ;
Salusky, IB .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1478-1483
[5]   Arterial stiffening and vascular calcifications in end-stage renal disease [J].
Guérin, AP ;
London, GM ;
Marchais, SJ ;
Metivier, F .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (07) :1014-1021
[6]   Publication bias in clinical trials due to statistical significance or direction of trial results [J].
Hopewell, Sally ;
Loudon, Kirsty ;
Clarke, Mike J. ;
Oxman, Andrew D. ;
Dickersin, Kay .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01)
[7]   Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia:: A 6-month, randomized, comparative trial versus calcium carbonate [J].
Hutchison, AJ ;
Maes, B ;
Vanwalleghem, J ;
Asmus, G ;
Mohamed, E ;
Schmieder, R ;
Backs, W ;
Jamar, R ;
Vosskühler, A .
NEPHRON CLINICAL PRACTICE, 2005, 100 (01) :C8-C19
[8]   The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis [J].
Jamal, Sophie A. ;
Fitchett, David ;
Lok, Charmaine E. ;
Mendelssohn, David C. ;
Tsuyuki, Ross T. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (10) :3168-3174
[9]   Discrepancies between meta-analyses and subsequent large randomized, controlled trials [J].
LeLorier, J ;
Gregoire, G ;
Benhaddad, A ;
Lapierre, J ;
Derderian, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (08) :536-542
[10]   Economic evaluation of sevelamer in patients with end-stage renal disease [J].
Manns, Braden ;
Klarenbach, Scott ;
Lee, Helen ;
Culleton, Bruce ;
Shrive, Fiona ;
Tonelli, Marcello .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (10) :2867-2878
12